Microbiology & Virology


Furthermore, small molecules enable selective modulation of the microbiome, balancing interactions between beneficial and pathogenic microorganisms. Coupled with advances in high-throughput screening technologies, they continue to overcome limitations related to target specificity and drug resistance, thereby serving as a crucial bridge between basic research and clinical anti-infective practice. Collectively, small-molecule compounds offer diversified solutions to global public health challenges.
-
A8433 FlucytosineSummary: Antifungal drug -
B2094 Fluconazole8 CitationTarget: Cytochrome P450 (CYP450)Summary: fungal cytochrome P450 enzyme 14α-demethylase inhibitor -
C3998 AzaserineSummary: tumor-inhibiting antibiotic -
B2136 ZanamivirTarget: Influenza virusesSummary: Influenza A/B virus neuraminidases inhibitor -
C4588 Cefotaxime (sodium salt)Summary: cephalosporin antibiotic -
A3834 SQ1091 CitationSummary: Antibiotic for treatment of pulmonary TB -
A3202 Avermectin B1Summary: Insecticide -
A5786 Natamycin1 CitationSummary: Antifungal macrolide polyene -
A8311 Maraviroc6 CitationTarget: CCRSummary: Selective CCR5 antagonist,antiretroviral agent -
C5775 PsicofuranineSummary: inhibitor of xanthosine monophosphate (XMP) aminase

